Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis
- 30 September 2006
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 97 (3) , 375-381
- https://doi.org/10.1016/s1081-1206(10)60804-6
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitisClinical Therapeutics, 2005
- Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadineAnnals of Allergy, Asthma & Immunology, 2004
- Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2003
- Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadineAnnals of Allergy, Asthma & Immunology, 2003
- Update on nonallergic rhinitisAnnals of Allergy, Asthma & Immunology, 2001
- Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitisAnnals of Allergy, Asthma & Immunology, 2001
- Quality of life in patients with allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2000
- Diagnosis and Management of Rhinitis: Complete Guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and ImmunologyAnnals of Allergy, Asthma & Immunology, 1998
- A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute modelJournal of Allergy and Clinical Immunology, 1994
- Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status QuestionnaireJournal of Allergy and Clinical Immunology, 1994